<DOC>
	<DOC>NCT00407537</DOC>
	<brief_summary>To investigate whether a Caduet based treatment strategy might result in greater reduction in total cardiovascular risk as compared to usual care in subjects with hypertension and additional risk factors.</brief_summary>
	<brief_title>Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine, atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Hypertension with three additional risks factors (for example: smoking, type 2 diabetes, family history of early heart disease, history of stroke, age over 55 (men) and 65 (women) Subjects currently receiving a statin or stopped statin within 6 months prior to enrollment. Subjects with a history of myocardial infarction and subjects with coronary bypass graft or intracoronary interventions.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>